Literature DB >> 2328729

The cell type-specific octamer transcription factor OTF-2 has two domains required for the activation of transcription.

T Gerster1, C G Balmaceda, R G Roeder.   

Abstract

Many studies indicate that the cell type-specific transcription factor OTF-2 plays a central role in the lymphoid-specific transcription of immunoglobulin genes. In order to better understand the mechanisms regulating transcriptional selectivity, we have initiated a functional dissection of OTF-2. By mutagenesis of an OTF-2 cDNA and by subsequent transfection into non-lymphoid cells we have defined two domains that are required jointly for high levels of transcription from a lymphoid-specific target promoter. One of these domains, located at the extreme carboxy-terminus, is rich in proline. The other domain, which appears to represent a novel type, is located upstream of the POU-specific box and contains clusters of intermingled proline, glutamine and leucine residues. Point mutations that change either groups of glutamine or groups of leucine show that both types of amino acids are required for function. Our data indicate that a high content in a particular amino acid does not necessarily suffice to generate a potent activation domain but that severe structural constraints may also play a major role.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2328729      PMCID: PMC551859          DOI: 10.1002/j.1460-2075.1990.tb08283.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  55 in total

1.  A human protein specific for the immunoglobulin octamer DNA motif contains a functional homeobox domain.

Authors:  H S Ko; P Fast; W McBride; L M Staudt
Journal:  Cell       Date:  1988-10-07       Impact factor: 41.582

Review 2.  Enhancer sequences and the regulation of gene transcription.

Authors:  M M Müller; T Gerster; W Schaffner
Journal:  Eur J Biochem       Date:  1988-10-01

3.  GAL4-VP16 is an unusually potent transcriptional activator.

Authors:  I Sadowski; J Ma; S Triezenberg; M Ptashne
Journal:  Nature       Date:  1988-10-06       Impact factor: 49.962

Review 4.  How eukaryotic transcriptional activators work.

Authors:  M Ptashne
Journal:  Nature       Date:  1988-10-20       Impact factor: 49.962

5.  A herpesvirus trans-activating protein interacts with transcription factor OTF-1 and other cellular proteins.

Authors:  T Gerster; R G Roeder
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

6.  OVEC, a versatile system to study transcription in mammalian cells and cell-free extracts.

Authors:  G Westin; T Gerster; M M Müller; G Schaffner; W Schaffner
Journal:  Nucleic Acids Res       Date:  1987-09-11       Impact factor: 16.971

7.  Transcription in yeast activated by a putative amphipathic alpha helix linked to a DNA binding unit.

Authors:  E Giniger; M Ptashne
Journal:  Nature       Date:  1987 Dec 17-23       Impact factor: 49.962

8.  The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins.

Authors:  W H Landschulz; P F Johnson; S L McKnight
Journal:  Science       Date:  1988-06-24       Impact factor: 47.728

9.  Structural and functional characterization of the short acidic transcriptional activation region of yeast GCN4 protein.

Authors:  I A Hope; S Mahadevan; K Struhl
Journal:  Nature       Date:  1988-06-16       Impact factor: 49.962

10.  Transcription factor OTF-1 is functionally identical to the DNA replication factor NF-III.

Authors:  E A O'Neill; C Fletcher; C R Burrow; N Heintz; R G Roeder; T J Kelly
Journal:  Science       Date:  1988-09-02       Impact factor: 47.728

View more
  59 in total

1.  Promoters with the octamer DNA motif (ATGCAAAT) can be ubiquitous or cell type-specific depending on binding affinity of the octamer site and Oct-factor concentration.

Authors:  I Kemler; E Bucher; K Seipel; M M Müller-Immerglück; W Schaffner
Journal:  Nucleic Acids Res       Date:  1991-01-25       Impact factor: 16.971

2.  Oct2 transactivation from a remote enhancer position requires a B-cell-restricted activity.

Authors:  A Annweiler; M Müller-Immerglück; T Wirth
Journal:  Mol Cell Biol       Date:  1992-07       Impact factor: 4.272

3.  Mapping the transactivation domain of the Oct-6 POU transcription factor.

Authors:  D Meijer; A Graus; G Grosveld
Journal:  Nucleic Acids Res       Date:  1992-05-11       Impact factor: 16.971

4.  Regulation and a possible stage-specific function of Oct-2 during pre-B-cell differentiation.

Authors:  C L Miller; A L Feldhaus; J W Rooney; L D Rhodes; C H Sibley; H Singh
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

5.  Nucleotide sequence of mouse SCIP cDNA, a POU-domain transcription factor.

Authors:  E C Zimmerman; C M Jones; V Fet; B L Hogan; M A Magnuson
Journal:  Nucleic Acids Res       Date:  1991-02-25       Impact factor: 16.971

6.  Conservation and divergence of NF-Y transcriptional activation function.

Authors:  E Serra; K Zemzoumi; A di Silvio; R Mantovani; V Lardans; C Dissous
Journal:  Nucleic Acids Res       Date:  1998-08-15       Impact factor: 16.971

7.  Coactivation by OCA-B: definition of critical regions and synergism with general cofactors.

Authors:  Y Luo; H Ge; S Stevens; H Xiao; R G Roeder
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

8.  The different alternatively spliced isoforms of the Oct-2 transcription factor repress the involucrin promoter in a cell type-specific manner.

Authors:  C M Chapman; D S Latchman
Journal:  Mol Biol Rep       Date:  1998-11       Impact factor: 2.316

9.  Molecular cloning of a novel human cDNA encoding a zinc finger protein that binds to the interleukin-3 promoter.

Authors:  N Koyano-Nakagawa; J Nishida; D Baldwin; K Arai; T Yokota
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

10.  The genomic structure of the human AP-2 transcription factor.

Authors:  R Bauer; A Imhof; A Pscherer; H Kopp; M Moser; S Seegers; M Kerscher; M A Tainsky; F Hofstaedter; R Buettner
Journal:  Nucleic Acids Res       Date:  1994-04-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.